|How has your practice changed since the emergence of CA-MRSA?|
|Bacterial Epidemiology||Majority is CA-MRSA.|
Increased case numbers but not severity.|
Increased recurrences, household transmission and incidence among infants.
Substantial patient fear of CA-MRSA.
Antibiotics are highly important and routinely prescribed.|
Some increased empiric prescribing of antibiotics that treat CA-MRSA.
|Surgical Management||Variable perception of importance of I&D.|
|Diagnostic Testing||Increased use of bacterial culture.|
|Prevention and Follow-up||
More aggressive follow-up.|
Uncertainty about role of decolonization.
|What is your knowledge about SSTI treatment recommendations and how do you stay updated?|
|Limited awareness of published recommendations from CDC and AAP.|
|What are the barriers to compliance with current recommendations?|
|Lack of awareness of current guidelines.|
|Inexperience with antibiotics that treat CA-MRSA.|
|Lack of self-efficacy with I&D.|
|Skepticism about treatment with I&D alone.|
|Concerns about antibiotic compliance.|
|Lack of epidemiologic data about resistance patterns for SSTIs.|
|Lack of resources to perform office I&D.|
|Delays in receiving culture results.|